Despite a solid price jump, investors doubt the company's fu...
Despite a solid price jump, investors doubt the company's future growth. The strong earnings outlook suggests potential risks, possibly causing earnings instability and pressure on the P/E ratio.
Market Might Still Lack Some Conviction On Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) Even After 45% Share Price Boost
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment